Format

Send to

Choose Destination
Ter Arkh. 1999;71(8):55-8.

[Garlic effectiveness in rheumatoid arthritis].

[Article in Russian]

Abstract

AIM:

To perform of clinical trial of alisate--a garlic preparation produced in Russia.

MATERIALS AND METHODS:

An open controlled trial of alisate enrolled 30 patients with rheumatoid arthritis (RA). 15 patients with RA of varying clinical form, stage and activity were given alisate in a dose 300 mg (1 tablet) twice a day for 4-6 weeks. 15 control RA patients received conventional antirheumatic therapy.

RESULTS:

The alisate group achieved a good and partial response in 86.5% of cases. The drug was well tolerated and had no side effects. In control group, some parameters changed for the worse.

CONCLUSION:

Alisate can be recommended for treatment of RA patients in combined and monotherapy.

PMID:
10515039
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center